Except for the Hras mutation, which was shared by three tumors from M1, no SNVs were recurrent in other tumors, even those obtained from the same mouse for validation, indicating the independent origin of tumors and the high heterogeneity of inter-tumors in this hepatitis-related primary HCC mouse model. This evidence concerns the gene HRAS and hepatocellular carcinoma.